Micron Biomedical, a clinical-stage biotechnology company advancing needle-free vaccines and therapeutics, today announced ...

Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 ...

A major genetic analysis of over 3,200 Japanese individuals reveals a more complex ancestry than previously thought, ...

Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant growth in the U.S. market Gene Expression Analysis Market Gene Expression ...

Relationship of pro-angiogenic factor Cyr61to colorectal cancer development and prognosis. Background: Microarrays are widely used to study gene expression patterns in cancer. In colorectal cancer, it ...

Next generation genomics technology is playing a significant role in improving the outcomes of genomic tools used in livestock farming, cultivation of crops, selection of quality seeds with improved ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

As genetic analysis expands to serve everything from population-scale studies to precision-driven clinical decisions, laboratories are under growing pressure to move faster while managing increasingly ...

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...